Lesaka Technologies Inc: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 7, 2025 and accepted by EDGAR at May 7, 2025, 20:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $135.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $428.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $91.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2024-07-01 to 2025-03-31 | $303.4m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $34.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-07-01 to 2025-03-31 | $97.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | $569.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | $1.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-01-01 to 2025-03-31 | −$2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-07-01 to 2025-03-31 | −$9.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$22.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$58.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$0.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | −$0.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | −$0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 78,347,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 69,724,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | $10.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | −$2.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $2.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 9 months2024-07-01 to 2025-03-31 | $13.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2025-01-01 to 2025-03-31 | $27.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Share repurchases | 9 months2024-07-01 to 2025-03-31 | $12.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-31 | $71.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $212.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $649.2m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $155.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $368.2m | us-gaap:Liabilities |
| Long-term debt | At period end2025-03-31 | $166.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-03-31 | $28.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-03-31 | $185.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001562762-25-000106. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.